| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | -0.0041 | 0.9 |
| mRNA | PF-4800567 hydrochloride | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0044 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.01 | 0.9 |